IRIS
GITTO, Rosaria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.582
EU - Europa 13.357
AS - Asia 6.556
SA - Sud America 2.169
AF - Africa 195
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 8
Totale 41.879
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.361
RU - Federazione Russa 7.072
SG - Singapore 2.801
BR - Brasile 1.873
CN - Cina 1.620
IE - Irlanda 1.569
SE - Svezia 1.335
VN - Vietnam 673
IT - Italia 664
UA - Ucraina 611
HK - Hong Kong 599
DE - Germania 573
GB - Regno Unito 383
FR - Francia 376
FI - Finlandia 313
IN - India 300
AR - Argentina 107
CA - Canada 105
BD - Bangladesh 74
PL - Polonia 74
MX - Messico 69
IQ - Iraq 67
JP - Giappone 63
CZ - Repubblica Ceca 61
BE - Belgio 58
NL - Olanda 58
AT - Austria 53
ZA - Sudafrica 52
TR - Turchia 51
EC - Ecuador 48
MA - Marocco 47
UZ - Uzbekistan 38
CI - Costa d'Avorio 33
ES - Italia 31
CO - Colombia 28
ID - Indonesia 28
VE - Venezuela 26
CL - Cile 25
PK - Pakistan 25
PY - Paraguay 21
SA - Arabia Saudita 20
UY - Uruguay 17
JO - Giordania 16
AE - Emirati Arabi Uniti 15
EG - Egitto 15
GR - Grecia 15
IR - Iran 15
AZ - Azerbaigian 14
PH - Filippine 14
PE - Perù 13
LT - Lituania 12
LV - Lettonia 12
OM - Oman 12
MY - Malesia 11
NO - Norvegia 11
AL - Albania 10
BO - Bolivia 10
KE - Kenya 10
RO - Romania 10
DO - Repubblica Dominicana 9
IL - Israele 9
KZ - Kazakistan 9
NP - Nepal 9
KR - Corea 8
LB - Libano 8
DZ - Algeria 7
JM - Giamaica 7
KG - Kirghizistan 7
NZ - Nuova Zelanda 7
PA - Panama 7
PS - Palestinian Territory 7
PT - Portogallo 7
SK - Slovacchia (Repubblica Slovacca) 7
TN - Tunisia 7
AM - Armenia 6
HN - Honduras 6
AU - Australia 5
CH - Svizzera 5
CR - Costa Rica 5
LK - Sri Lanka 5
MD - Moldavia 5
NI - Nicaragua 5
SN - Senegal 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BG - Bulgaria 4
ET - Etiopia 4
GE - Georgia 4
GT - Guatemala 4
HU - Ungheria 4
IS - Islanda 4
LU - Lussemburgo 4
RS - Serbia 4
TH - Thailandia 4
AO - Angola 3
BH - Bahrain 3
CY - Cipro 3
DK - Danimarca 3
EE - Estonia 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
Totale 41.840
Salva come PNG Salva come JPEG
Città #
Dallas 10.071
Moscow 2.023
Dublin 1.567
Singapore 1.540
Ashburn 1.440
Chandler 1.189
Jacksonville 1.139
Nyköping 862
Beijing 609
Hong Kong 594
San Jose 371
Dong Ket 358
Los Angeles 309
Princeton 254
The Dalles 251
Dearborn 244
Lauterbourg 228
Cambridge 215
Medford 210
Des Moines 189
Messina 180
Ann Arbor 158
Boardman 150
Hyderabad 125
São Paulo 121
Buffalo 116
New York 110
Munich 109
Ho Chi Minh City 107
Woodbridge 89
Lancaster 86
Hanoi 78
Guangzhou 72
Wilmington 69
Tianjin 68
Pune 64
Orem 62
Warsaw 56
Redondo Beach 55
Brussels 53
Frankfurt am Main 53
San Mateo 53
Turku 52
Belo Horizonte 50
Jinan 50
Seattle 49
Tokyo 49
Brooklyn 48
Milan 48
Rio de Janeiro 48
Santa Clara 44
Brno 43
Vienna 42
Shenyang 41
Catania 39
Chicago 39
Denver 39
Council Bluffs 38
Tashkent 38
London 37
Johannesburg 36
Atlanta 35
Phoenix 35
Brasília 34
Houston 34
Abidjan 33
Amsterdam 33
Montreal 32
Rome 32
Nanjing 31
Baghdad 30
Stockholm 29
Chennai 28
Haikou 28
Helsinki 28
Curitiba 27
Shanghai 27
Manchester 26
Nuremberg 26
Toronto 25
Washington 25
Porto Alegre 24
Poplar 21
Taizhou 21
Zhengzhou 21
Guayaquil 20
Hangzhou 20
Boston 19
Düsseldorf 19
Fuzhou 19
Lappeenranta 19
Ningbo 19
Dhaka 18
Ottawa 18
Ribeirão Preto 18
San Francisco 18
Fortaleza 17
Francofonte 17
Goiânia 17
Nanchang 17
Totale 27.487
Salva come PNG Salva come JPEG
Nome #
[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines: synthesis and stereochemistry 4.725
[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines: stereochemistry and anticonvulsant activity 4.705
1-aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: Novel AMPA receptor antagonists 296
1-Aryl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamide derivatives: synthesis and biological evaluation 268
1-Aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: non-competitive AMPA receptors antagonists 267
1,4-benzodiazepine derivatives as anticonvulsant agents in DBA/2 mice 255
Chemical exploration of 4-(4-fluorobenzyl)piperidine fragment for the development of new tyrosinase inhibitors 253
1-Benzylpiperidine derivatives: design and synthesis of new compounds as tyrosinase inhibitors from Agaricus bisporus 220
4-Fluorobenzylpiperazine-Containing Derivatives as Efficient Inhibitors of Mushroom Tyrosinase 213
4,5-Dihydro-7,8-dimethoxy-1-phenyl-3H-2,3-benzodiazepin-4-one 207
3,5-dihydro-4H-2,3-benzodiazepine-4-thiones: A new class of AMPA receptor antagonists 206
Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases 202
AMPA receptor antagonists: Synthesis and pharmacological evaluation 201
7,8-methylenedioxy-4H-2,3-benzodiazepin-4-ones as novel AMPA receptor antagonists 197
Anticonvulsant agent: enhancement of physicochemical properties 195
Exploiting the 1-(4-fluorobenzyl)piperazine fragment for the development of novel tyrosinase inhibitors as anti-melanogenic agents: Design, synthesis, structural insights and biological profile 195
Targeting Tyrosinase: Development and Structural Insights of Novel Inhibitors Bearing Arylpiperidine and Arylpiperazine Fragments 194
5-Phenyl-9H-1,3-dioxolo[4,5-h][2,3]-benzodiazepin-8(7H)-one 193
Seeking new approach for therapeutic treatment of cholera disease via inhibition of bacterial carbonic anhydrases: experimental and theoretical studies for sixteen benzenesulfonamide derivatives 189
5H-[1,2,4]OXADIAZOLO[5,4-D][1,5]BENZOTHIAZEPINES - SYNTHESIS AND STEREOCHEMISTRY 188
4-[1-(4-Fluorobenzyl)-4-hydroxy-1H-indol-3-yl]-2-hydroxy-4-oxobut-2-enoic acid as a prototype to develop dual inhibitors of HIV-1 integration process. 187
A Combination of Pharmacophore and Docking-based Virtual Screening to Discover new Tyrosinase Inhibitors 187
5H-[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines as anticonvulsant agents in DBA/2 mice. 186
Exploring structural properties of potent human carbonic anhydrase inhibitors bearing a 4-(cycloalkylamino-1-carbonyl)benzenesulfonamide moiety 184
Looking toward the Rim of the Active Site Cavity of Druggable Human Carbonic Anhydrase Isoforms 183
Computational methods to analyze and predict the binding mode of inhibitors targeting both human and mushroom tyrosinase 181
Identification of Potent and Selective Human Carbonic Anhydrase VII (hCA VII) Inhibitors 181
InVivo Evaluation of Selective Carbonic Anhydrase Inhibitors as Potential Anticonvulsant Agents 181
Discovery of a new potent inhibitor of mushroom tyrosinase (Agaricus bisporus) containing 4-(4-hydroxyphenyl)piperazin-1-yl moiety 179
4-Sulfamoylphenylalkylamides as Inhibitors of Carbonic Anhydrases Expressed in Vibrio cholerae 179
3D Pharmacophore model and synthesys of NMDA receptor subunit NR2B antagonists 178
A structure-based approach to ligand discovery for inhibition of HIV-1 IN-LEDGF/p75 interaction: a new target for anti-AIDS therapy 178
Design and optimization of isoquinoline-sulfonamides as potent and selective inhibitors of human carbonic anhydrase VII 177
Carbonic anhydrase inhibitors: Design, synthesis and structural characterization of new heteroaryl-N-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms 177
Discovery of benzimidazole-based Leishmania mexicana cysteine protease CPB2.8ΔCTE inhibitors as potential therapeutics for leishmaniasis 177
Design and synthesis of acetylcholinesterase inhibitors 176
Synthesis and biochemical evaluation of 5-(pyridin-4-yl)-4H-1,2,4-triazol-4-amine-based inhibitors of tyrosinase from Agaricus bisporus 174
A new potential approach to block HIV-1 replication via protein–protein interaction and strand-transfer inhibition 170
2,3-Benzodiazepines as potential AMPA receptors antagonists 169
Rational design of small molecules able to inhibit α-synuclein amyloid aggregation for the treatment of Parkinson’s disease 169
7,9-Dihydro-1,3-dioxolo[4,5-h][2,3]benzodiazepin-8(7H)-ones as anticonvulsant agents 167
P158-DEVELOPMENT OF FLEXIBLE ARYLSULFONAMIDES AS POTENTIAL MULTITARGET ANTICANCER AGENTS 165
Analysis of structure-activity relationships in a series of 4-(1-piperazinyl)phenol-based derivatives as competitive inhibitors of Tyrosinase 165
HIV-1 integrase strand-transfer inhibitors: Design, synthesis and molecular modeling investigation 164
Synthesis, resolution, stereochemistry, and molecular modeling of (R)- and (S)-2-acetyl-1-(4 '-chlorophenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline AMPAR antagonists 163
Antiretroviral strategy using multi-target agents 162
7,11b-dihydro-9,10-dimethoxy-3,11b- diphenyl[1,2,4]oxadiazolo[5,4-a]-[2,3]benzodiazepin-6(5H)-one 161
DISCOVERY OF NEW INDOLE DERIVATES AS NEUROPROTECTIVE AGENTS 161
In Silico-Guided Identification of New Potent Inhibitors of Carbonic Anhydrases Expressed in Vibrio cholerae 161
Discovery of potent and selective inhibitors of druggable carbonic anhydrase isoforms 160
3D Pharmacophore Models for 1,2,3,4-Tetrahydroisoquinoline Derivatives Acting as Anticonvulsant Agents 160
Synthesis and biological evaluation of sulfonamide-based compounds as inhibitors of carbonic anhydrase from Vibrio cholerae 159
Small molecules targeting the interaction between HIV-1 integrase and LEDGF/p75 cofactor. 159
Identification of isoquinoline-sulfonamides as potent and selective carbonic anhydrase inhibitors 159
In Silico Strategy for Targeting the mTOR Kinase at Rapamycin Binding Site by Small Molecules 157
Combined strategies for the discovery of ionotropic glutamate receptor antagonists 156
2-Acetil-1-(4'-clorofenil)-6,7-dimetossi-1,2,3,4-tetraidroisochinolina (Ps3Ac) Potente AMPA-antagonista: Definizione del Profilo Enantiofarmacobiologico 156
3D pharmacophore model and the synthesis of NMDA receptor subunit NR2B antagonists 156
Evaluation of 4-(4-Fluorobenzyl)piperazin-1-yl]-Based Compounds as Competitive Tyrosinase Inhibitors Endowed with Antimelanogenic Effects 156
Anticonvulsant activity and plasma level of 2,3-benzodiazepin- 4-ones (CFMs) in genetically epilepsy-prone rats 155
Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as Potent Carbonic Anhydrase Inhibitors: Synthesis, Biological Evaluation, and Enzyme−Ligand X-ray Studies 155
Novel Potent Anticonvulsant Agent Containing a Tetrahydroisoquinoline Skeleton. 154
ENANTIOSEPARATION AND COMPLEXATION STUDIES ON 2,3-BENZODIAZEPINES 153
Nuovi ligandi del recettore NR2B/NMDA a struttura indolica 152
Searching for indole derivatives as potential mushroom tyrosinase inhibitors 152
Design, synthesis and in vitro evaluation of 4-fluorobenzyl- and 4-hydroxyphenyl-based compounds targeting tyrosinases 152
Nuovi selettivi inibitori dell'anidrasi carbonica: sintesi, SAR e studi sull'interazione enzima/inibitore 151
Leveraging the 3-Chloro-4-fluorophenyl Motif to Identify Inhibitors of Tyrosinase from Agaricus bisporus 150
Binding mode investigation and SAR studies of HIV-1 integrase inhibitors 150
Annelated 1,5-benzothiazepines 150
From NMDA receptor antagonists to discovery of selective σ2 receptor ligands 149
Synthesis of new pyridazine derivatives as potential anti-HIV-1 agents 148
Synthesis and structure-active relationship of 1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline anticonvulsants 148
INVESTIGATION ON PYRIDINYL-1,2,4-TRIAZOLE-BASED COMPOUNDS AS -SYN AGGREGATION INHIBITORS FOR TREATING PARKINSON’S DISEASE 148
Binding modes of noncompetitive AMPA antagonists: a computational approach 147
ANNELATED 1,5-BENZODIAZEPINES .2. 6 MEMBERED RINGS 147
ANNELATED 1,5-BENZODIAZEPINES .1. 3-MEMBERED, 4-MEMBERED, AND 5-MEMBERED RINGS. 147
Structural optimization and in vitro evaluation of new 1-(4-fluorobenzyl)piperazine derivatives as inhibitors of Tyrosinase from Agaricus bisporus 147
PROGETTAZIONE E SINTESI DI NUOVI DKA ANALOGHI COME POTENZIALI INIBITORI DELL’INTEGRASI DELL’HIV-1 146
Antiretroviral strategy: design and synthesis of HIV-1 IN-LEDGF/p75 interaction inhibitors 146
Small Molecules Targeting Protein–Protein Interactions: A Promising Anti-HIV Strategy 146
Anticonvulsant activity of tetrahydroisoquinoline derivatives as potential new AMPA receptor antagonists 144
Probing the molecular interactions between the human Carbonic Anhydrases (hCAs) and a novel class of benzenesulfonamides 143
Serendipitous discovery of indole derivatives as potent tyrosinase inhibitors 142
Exploring the MUC1/CIN85 interaction to investigate a small library of peptide inhibitors as potential anti-metastatic agents 142
Searching for alpha-syn inhibitors to fight Parkinson’s disease 142
Exploring the chemical space of 3-chloro-4-fluorophenyl-based compounds as tyrosinase inhibitors 140
ELECTRONIC-PROPERTIES OF THIENODIAZEPINE AND BENZODIAZEPINE DERIVATIVES 140
Ligand-Based Discovery of a Small Molecule as Inhibitor of α-Synuclein Amyloid Formation 139
PROGETTAZIONE E SINTESI DI NUOVI DKA ANALOGHI COME POTENZIALI INIBITORI DELL'INTEGRASI DELL'HIV-1 139
Discovery of HIV-1 Integrase and cellular cofactor LEDGF/p75 interaction inhibitors 138
Discovery and optimization of isoquinoline-derived inhibitors of human Carbonic Anhydrases (hCAs) 138
Nuovi Antagonisti Noncompetitivi del Recettore AMPA a struttura tetraidroisochinolinica, 137
Computational Studies to Discover a New NR2B/NMDA Receptor Antagonist and Evaluation of Pharmacological Profile 137
PROGETTAZIONE E SINTESI DI NUOVI DERIVATI ISOCHINOLINICI COME AGENTI ANTICONVULSIVANTI MULTITARGET 135
The 1-(4-fluorobenzyl)piperazine fragment for the development of novel tyrosinase inhibitors 135
Synthesis and evaluation of pharmacological profile of 1-aryl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamides. 134
Discovery of a novel class of Tyrosinase inhibitors as antimelanogenic agents 134
Computational studies and synthetic approaches for the identification of new protein-protein interaction inhibitors (PPI) 133
Computational and synthetic approaches for developing Lavendustin B derivatives as allosteric inhibitors of HIV-1 integrase 133
Totale 25.907
Salva come PNG Salva come JPEG
Categoria #
all - tutte 112.258
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 112.258
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021825 0 0 0 0 0 0 0 0 0 211 162 452
2021/20221.596 38 201 32 66 64 30 135 59 38 79 320 534
2022/20234.717 368 418 208 423 348 464 94 242 1.912 16 168 56
2023/20241.343 94 189 81 253 107 235 20 64 5 155 23 117
2024/20255.302 83 103 124 311 248 150 149 1.203 1.297 318 493 823
2025/202624.187 733 3.519 7.511 1.313 1.281 3.676 1.817 1.959 1.875 503 0 0
Totale 42.235